+151.8%
MRNA vs AS
-20.4%
+172.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | AS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +3.6% | -5.8% | -4.6% |
| 7D | +5.5% | -4.9% | +10.4% | +8.9% |
| 30D | +158.7% | -19.6% | +178.3% | +195.3% |
| 3M | +182.1% | -14.4% | +196.5% | +214.0% |
| 6M | +151.8% | -20.1% | +171.9% | +185.6% |
| All | +151.8% | -20.4% | +172.2% | +185.6% |
Cumulative growth
Daily Returns
Daily percentage return beside AS.
Daily Out/Under-Performance
Portfolio return minus AS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded AS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling